Ted Dunn
Family Medicine · Mt Pleasant, SCNPI 1578527768
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 186 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations.
Across 186 payments — averaging $16.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$381
- AbbVie$375
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$326
- Lilly USA, LLC$262
- AstraZeneca$235
- Takeda Pharmaceuticals U.S.A., Inc.$156
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,996100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $381 |
| AbbVie(2 entities) | 31 | $375 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $326 |
| Lilly USA, LLC | 17 | $262 |
| AstraZeneca | 15 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $156 |
| Pfizer | 7 | $128 |
| Novartis | 6 | $115 |
| Teva Pharmaceuticals USA, Inc. | 8 | $109 |
| Exact Sciences | 5 | $108 |
| Amgen | 6 | $93 |
| Esperion Therapeutics, Inc. | 4 | $67 |
| Boehringer Ingelheim | 4 | $65 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| Shire North American Group Inc | 4 | $54 |
| Amarin Pharma, Inc. | 3 | $52 |
| Abbott | 2 | $49 |
| Johnson & Johnson | 3 | $42 |
| Astellas Pharma US Inc | 2 | $37 |
| Phadia US Inc. | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $26 |
| Dexcom, Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Mannkind Corporation | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $13 |
| GSK | 1 | $13 |
| Merck | 1 | $13 |
| Boston Scientific | 1 | $11 |
| Neuronetics, Inc. | 1 | $10 |
How this compares
$2,996 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 37 | $678 |
| Omeprazole | 14 | $280 |
| Tamsulosin Hcl | 12 | $244 |
| Lisinopril | 16 | $171 |
| Losartan Potassium | 14 | $164 |
| Pantoprazole Sodium | 11 | $149 |
| Levothyroxine Sodium | 16 | $148 |
| Rosuvastatin Calcium | 13 | $128 |
| Amlodipine Besylate | 18 | $104 |
| Simvastatin | 14 | $88 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Mt Pleasant
- Richard WilkesMt Pleasant$216K
- Valerie ScottMt Pleasant$23K
- Andrew FlandryMt Pleasant$15K
- Scott EvansMt Pleasant$13K
- Stephen BruntonWinnsboro$1.3M
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
- Terry NagelColumbia$112K
- Katherine JohnsonGreenwood$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.